Abstract
Comparative assays were carried out to determine the median protective dose of both live and inactivated Newcastle disease vaccines using a range of challenge strains. Significant variation between challenge strains was found with both types of vaccine using challenge administered by aerosol or by intramuscular injection. In order that the protective capacities of vaccines may be compared on an international scale, the use of a standardized challenge strain is recommended.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
